Close
Emit® 2000 Mycophenolic Acid Assay*
MPA concentrations are highly variable in patients receiving the drug. As such, treatment needs to be individualized depending on transplant type, co-administrated drugs, time post transplant, and other factors. The Emit 2000 MPA assay is a simple, easy-to-use solution to help clinicians better manage MPA therapy in transplant patients.
Features
- Results available within 10 minutes
- Utilizes plasma samples - no pretreatment required
- Assay can be performed alongside 3 other immunosuppressive drugs
- Excellently correlation to the HPLC reference method
Advantages
- Streamlined ISD monitoring for enhanced productivity
- Excellent analytical performance for confidence in results
- Benefit from up to 4 different ISD methods on one single V-Twin® or Viva-E® drug testing system
Assay Specifications
| Emit 2000 MPA Assay | |
|---|---|
| Product Code | 6R919UL |
| Sample Type | EDTA or Heparinized plasma |
| Pretreatment | None |
| Reportable Range | 0.1 μg/mL–15 μg/mL |
| Calibration | With new reagent lot |
| Reagent Stability | Opened - until expiration date |
Enduring Expertise for Your Immunosuppressant Drug Testing Needs.
With recognized drug testing expertise, Siemens Healthcare Diagnostics offers a comprehensive and expanding menu of tests across multiple instrument solutions to meet the immunosuppressant drug (ISD) testing needs of customers in any setting.
Learn more about the ISD offerings from Siemens
Learn more about organ transplantation
Learn more about ISD monitoring
Learn more about mycophenolic acid
*Not available for sale in the US.
